BCL2 and pancreatic neoplasm: Luteolin, as a natural small molecule inhibitor of BCL-2, shows pro-apoptotic activity in SW1990 pancreatic cancer cells promotes BAX release, and induces cancer cell death by directly binding to BCL-2.